To cite this paper use one of the standards below:
The human dihydroorotate dehydrogenase (hDHODH), a crucial flavin-dependent mitochondrial enzyme in the de novo pyrimidine synthesis, has been considered a promising therapeutic target to tackle tumor progression and viral infection since infectious viruses such as the SARS-CoV-2, a current global threat to public health,
require host factors including hDHODH for viral replication. Therefore, the development of selective hDHODH inhibitors as host-targeting antivirals (HTAs) may lead to effective broad-spectrum antiviral agents with minimal drug resistance induction as an alternative to Leflunomide, Teriflunomide, and Brequinar, which have known efficacy and toxicity issues. Based on the interaction profile of quinone-based molecules in the ubiquinone binding site of hDHODH, we rationalized that the heterocyclic scaffolds quinazolinone and quinoxalinone
could mimic important hydrogen-bonding interactions. Two linear synthetic routes were successfully established to obtain functionalized quinazolinones and quinazolinones which are under evaluation via enzymatic assays with hDHODH.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper